Table 3 Clinical, demographic and laboratory data according to the agreement between glycemia obtained from glucometer and the logbook records

N (%)

41 (26.8)

112 (73.2)

Gender, female n (%)

25 (61.0)

52 (46.4)

Duration of diabetes (year), median [IQR]

8.0 [17.0]

10.0 [13.0]

Age (year), mean ± SD

27.7 ± 15.2

26.3 ± 15.7

Mean age at diagnosis (year), mean ± SD

15.1 ± 10.6

15.2 ± 9.9

Age range, n (%)

 1–13 year

9 (22.0)

9 (8.0)

 14–19 year

8 (19.6)

30 (26.8)

 > 19 year

24 (58.6)

73 (65.2)

Years of study (year), mean ± SD^a

9.6 ± 4.8

10.3 ± 3.6

Time of follow-up (year), median [IQR]

8 [17.0]

9 [13.7]

Ethnicity, n (%)

 Caucasian

24 (58.5)

57 (50.9)

Economic status, n (%)

 High

0

0

 Medium

10 (24.4)

20 (17.9)

 Low

27 (65.9)

83 (74.1)

 Very low

4 (9.8)

9 (8.0)

Living in Rio de Janeiro City, yes n (%)

31 (75.6)

90 (80.4)

Insulin U/kg

0.8 ± 0.4

0.8 ± 0.2

Glycemic control

 HbA1c (%), baseline

8.9 ± 1.8

9.6 ± 2.3

 HbA1c (mmol/mol), baseline

82.1 ± 25.9

74.6 ± 20.8

 HbA1c (%), final

8.6 ± 1.6

9.1 ± 1.9

 HbA1c (mmol/mol), final

76.9 ± 21.3

70.9 ± 17.6

 HbA1c (%), mean in 1 year

8.7 ± 1.3

9.4 ± 1.8

 HbA1c (mmol/mol), mean in 1 year

79.8 ± 19.5

71.7 ± 14.2

 HbA1c (good), baseline; n (%)^b

7 (17.0)

18 (16.0)

 HbA1c baseline ≥ 9.0%; n (%)^c

18 (43.9)

62 (55.5)

 Hb1Ac (good), final; (%)^b

3 (7.3)

10 (8.9)

 HbA1c final ≥ 9.0%; n (%)^c

12 (29.2)

52 (46.4)

 HbA1c (good) (mean), (%)^b

3 (7.3)

6 (5.4)

 HbA1c mean, ≥ 9.0%; n (%)^c

15 (36.5)

54 (48.2)

Diabetes management

 SMBG, n

3.4 ± 1.1

3.2 ± 1.2

 Supply of glucose strips from SUS, n (%)

33 (80.5)

70 (62.5)

 Adherence to diet, yes n (%)

15 (36.6)

19 (17.0)

 BMI (kg/m²)

22.5 ± 4.5

23.7 ± 4.8